Michael Lishner
Impact in
- Oncology top 1%
- Cancer Risks and Factors
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
Papers in
- Hematology 46
- Multiple Myeloma Research and Treatments 24
- Chronic Myeloid Leukemia Treatments 11
- Oncology 72
- Cancer Risks and Factors 40
- Co-authors
- Gideon Koren (25 shared papers)David Pereg (21 shared papers)Mordchai Ravid (26 shared papers)Liat Drucker (44 shared papers)Avi Leader (11 shared papers)Avishay Elis (37 shared papers)Judith Radnay (28 shared papers)Aliza Amiel (33 shared papers)
- Journals
- Anti-Cancer Drugs (6 papers)European Journal Of Haematology (5 papers)Human Reproduction (5 papers)Blood (5 papers)Acta Haematologica (5 papers)
- Partner nations
- IsraelCanadaUnited States
In The Last Decade
Michael Lishner
245 papers receiving 6.3k citations
Peers
Comparison fields: 5 of 148
- Oncology 2.4k
- Hematology 774
- Genetics 619
- Obstetrics and Gynecology 270
- Hepatology 248
Countries citing papers authored by Michael Lishner
This map shows the geographic impact of Michael Lishner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Lishner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Lishner more than expected).
Fields of papers citing papers by Michael Lishner
This network shows the impact of papers produced by Michael Lishner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Lishner. The network helps show where Michael Lishner may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Lishner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 252 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 298 | |
| 2 | 2012 | 220 | |
| 3 | 1987 | 176 | |
| 4 | 1992 | 156 | |
| 5 | 2010 | 136 | |
| 6 | 1990 | 134 | |
| 7 | 2012 | 132 | |
| 8 | 2008 | 116 | |
| 9 | 1992 | 112 | |
| 10 | 2001 | 111 | |
| 11 | 1991 | 111 | |
| 12 | 2001 | 109 | |
| 13 | 2005 | 100 | |
| 14 | Complications associated with Ommaya reservoirs in patients with cancer. The Princess Margaret Hospital experience and a review of the literature. | 1990 | 96 |
| 15 | 2007 | 96 | |
| 16 | 2004 | 86 | |
| 17 | 1990 | 84 | |
| 18 | 2004 | 84 | |
| 19 | 1990 | 83 | |
| 20 | 1993 | 82 |
About Michael Lishner
Michael Lishner is a scholar working on Hematology, Oncology, Genetics, Pathology and Forensic Medicine and Cancer Research, having authored 252 papers that have together received 6.7k indexed citations. Recurring topics across this work include Cancer Risks and Factors (40 papers), Chronic Lymphocytic Leukemia Research (25 papers), Multiple Myeloma Research and Treatments (24 papers), Lymphoma Diagnosis and Treatment (18 papers), Acute Lymphoblastic Leukemia research (15 papers), Multiple and Secondary Primary Cancers (11 papers), Genomic variations and chromosomal abnormalities (11 papers) and Chronic Myeloid Leukemia Treatments (11 papers). The work is most often cited by research in Oncology (2.4k citations), Hematology (774 citations), Genetics (619 citations), Obstetrics and Gynecology (270 citations) and Hepatology (248 citations). Michael Lishner has collaborated with scholars based in Israel, Canada and United States. Frequent co-authors include Gideon Koren, David Pereg, Mordchai Ravid, Liat Drucker, Avi Leader, Avishay Elis, Judith Radnay, Aliza Amiel, Donna Zemlickis and Moshe D Fejgin. Their work appears in journals such as Anti-Cancer Drugs, European Journal Of Haematology, Human Reproduction, Blood and Acta Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.